DK0946151T3 - Doseringsform med stigende dosisfrigivelse - Google Patents
Doseringsform med stigende dosisfrigivelseInfo
- Publication number
- DK0946151T3 DK0946151T3 DK97947642T DK97947642T DK0946151T3 DK 0946151 T3 DK0946151 T3 DK 0946151T3 DK 97947642 T DK97947642 T DK 97947642T DK 97947642 T DK97947642 T DK 97947642T DK 0946151 T3 DK0946151 T3 DK 0946151T3
- Authority
- DK
- Denmark
- Prior art keywords
- dosage form
- increasing dose
- dose release
- release
- increasing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3174196P | 1996-11-25 | 1996-11-25 | |
US96760697A | 1997-11-10 | 1997-11-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0946151T3 true DK0946151T3 (da) | 2006-08-28 |
Family
ID=26707551
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97947642T DK0946151T3 (da) | 1996-11-25 | 1997-11-12 | Doseringsform med stigende dosisfrigivelse |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0946151B1 (da) |
JP (2) | JP5173089B2 (da) |
CN (2) | CN100477986C (da) |
AT (1) | ATE325606T1 (da) |
AU (1) | AU5267698A (da) |
CA (1) | CA2265668C (da) |
DE (1) | DE69735848T2 (da) |
DK (1) | DK0946151T3 (da) |
ES (1) | ES2264173T3 (da) |
HK (1) | HK1021620A1 (da) |
PT (1) | PT946151E (da) |
WO (1) | WO1998023263A1 (da) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6440457B1 (en) | 1993-05-27 | 2002-08-27 | Alza Corporation | Method of administering antidepressant dosage form |
US5922736A (en) | 1995-12-04 | 1999-07-13 | Celegene Corporation | Chronic, bolus administration of D-threo methylphenidate |
US6486177B2 (en) | 1995-12-04 | 2002-11-26 | Celgene Corporation | Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate |
US5837284A (en) * | 1995-12-04 | 1998-11-17 | Mehta; Atul M. | Delivery of multiple doses of medications |
US6919373B1 (en) | 1996-11-12 | 2005-07-19 | Alza Corporation | Methods and devices for providing prolonged drug therapy |
KR100827254B1 (ko) | 1998-06-03 | 2008-05-07 | 알자 코포레이션 | 연장된 약물 치료를 제공하기 위한 방법 및 장치 |
US6673367B1 (en) * | 1998-12-17 | 2004-01-06 | Euro-Celtique, S.A. | Controlled/modified release oral methylphenidate formulations |
US7083808B2 (en) | 1998-12-17 | 2006-08-01 | Euro-Celtique S.A. | Controlled/modified release oral methylphenidate formulations |
US6419960B1 (en) | 1998-12-17 | 2002-07-16 | Euro-Celtique S.A. | Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations |
US6395752B1 (en) * | 1999-03-04 | 2002-05-28 | Pharmaquest Limited | Method of treating depression using 1-threo-methylphenidate |
US6127385A (en) * | 1999-03-04 | 2000-10-03 | Pharmaquest Limited | Method of treating depression using l-threo-methylphenidate |
HUP0401079A3 (en) | 2001-07-10 | 2008-04-28 | Teva Pharma | Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery |
EP2172192A1 (en) | 2001-12-24 | 2010-04-07 | Teva Pharmaceutical Industries Ltd. | Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder of granular material, and process and tooling for producing it |
US20050232995A1 (en) | 2002-07-29 | 2005-10-20 | Yam Nyomi V | Methods and dosage forms for controlled delivery of paliperidone and risperidone |
US7988993B2 (en) | 2002-12-09 | 2011-08-02 | Andrx Pharmaceuticals, Inc. | Oral controlled release dosage form |
WO2005030182A1 (en) * | 2003-09-26 | 2005-04-07 | Alza Corporation | Controlled release formulations exhibiting an ascending rate of release |
US8541026B2 (en) | 2004-09-24 | 2013-09-24 | Abbvie Inc. | Sustained release formulations of opioid and nonopioid analgesics |
PL116330U1 (en) | 2005-10-31 | 2007-04-02 | Alza Corp | Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation |
WO2010077925A2 (en) | 2008-12-16 | 2010-07-08 | Teva Pharmaceutical Industries Ltd. | Drug delivery system for zero order, zero order biphasic, ascending or descending drug delivery of methylphenidate |
US10905652B2 (en) | 2011-03-23 | 2021-02-02 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
US9498447B2 (en) | 2011-03-23 | 2016-11-22 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
US8927010B2 (en) | 2011-03-23 | 2015-01-06 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
US9603809B2 (en) | 2011-03-23 | 2017-03-28 | Ironshore Pharmaceuticals & Development, Inc. | Methods of treatment of attention deficit hyperactivity disorder |
US9119809B2 (en) | 2011-03-23 | 2015-09-01 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
US9283214B2 (en) | 2011-03-23 | 2016-03-15 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
US10292937B2 (en) | 2011-03-23 | 2019-05-21 | Ironshore Pharmaceuticals & Development, Inc. | Methods of treatment of attention deficit hyperactivity disorder |
DK4011364T3 (da) | 2011-03-23 | 2024-03-18 | Ironshore Pharmaceuticals & Dev Inc | Fremgangsmåder og sammensætninger til behandling af ADD (Attention Deficit Disorder) |
US11241391B2 (en) | 2011-03-23 | 2022-02-08 | Ironshore Pharmaceuticals & Development, Inc. | Compositions for treatment of attention deficit hyperactivity disorder |
US8916588B2 (en) | 2011-03-23 | 2014-12-23 | Ironshore Pharmaceuticals & Development, Inc. | Methods for treatment of attention deficit hyperactivity disorder |
CA2936741C (en) | 2014-10-31 | 2018-11-06 | Purdue Pharma | Methods and compositions particularly for treatment of attention deficit disorder |
US10722473B2 (en) | 2018-11-19 | 2020-07-28 | Purdue Pharma L.P. | Methods and compositions particularly for treatment of attention deficit disorder |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4327725A (en) * | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
US5082668A (en) * | 1983-05-11 | 1992-01-21 | Alza Corporation | Controlled-release system with constant pushing source |
CA2007181C (en) * | 1989-01-06 | 1998-11-24 | Angelo Mario Morella | Sustained release pharmaceutical composition |
US5024843A (en) * | 1989-09-05 | 1991-06-18 | Alza Corporation | Oral hypoglycemic glipizide granulation |
JPH06502622A (ja) * | 1990-07-23 | 1994-03-24 | アルザ・コーポレーション | ニコチンを投与するための口腔浸透デバイス |
US5156850A (en) * | 1990-08-31 | 1992-10-20 | Alza Corporation | Dosage form for time-varying patterns of drug delivery |
US5166145A (en) * | 1990-09-10 | 1992-11-24 | Alza Corporation | Antiemetic therapy |
US5208037A (en) * | 1991-04-22 | 1993-05-04 | Alza Corporation | Dosage forms comprising polymers comprising different molecular weights |
WO1993006821A1 (en) * | 1991-10-04 | 1993-04-15 | Yoshitomi Pharmaceutical Industries, Ltd. | Sustained-release tablet |
US5532003A (en) * | 1994-01-18 | 1996-07-02 | Alza Corporation | Pentoxifylline therapy |
ZA953078B (en) * | 1994-04-28 | 1996-01-05 | Alza Corp | Effective therapy for epilepsies |
US5698224A (en) * | 1994-06-27 | 1997-12-16 | Alza Corporation | Tacrine therapy |
US5614578A (en) * | 1994-10-28 | 1997-03-25 | Alza Corporation | Injection-molded dosage form |
JP4393587B2 (ja) * | 1996-08-16 | 2010-01-06 | アルザ コーポレイション | 医薬の上昇性投与量を提供するための薬剤投与型 |
-
1997
- 1997-11-12 EP EP97947642A patent/EP0946151B1/en not_active Expired - Lifetime
- 1997-11-12 DE DE69735848T patent/DE69735848T2/de not_active Expired - Lifetime
- 1997-11-12 ES ES97947642T patent/ES2264173T3/es not_active Expired - Lifetime
- 1997-11-12 CA CA002265668A patent/CA2265668C/en not_active Expired - Lifetime
- 1997-11-12 CN CNB2004100929372A patent/CN100477986C/zh not_active Expired - Lifetime
- 1997-11-12 DK DK97947642T patent/DK0946151T3/da active
- 1997-11-12 JP JP52489598A patent/JP5173089B2/ja not_active Expired - Lifetime
- 1997-11-12 PT PT97947642T patent/PT946151E/pt unknown
- 1997-11-12 AT AT97947642T patent/ATE325606T1/de active
- 1997-11-12 AU AU52676/98A patent/AU5267698A/en not_active Abandoned
- 1997-11-12 WO PCT/US1997/022016 patent/WO1998023263A1/en active IP Right Grant
- 1997-11-12 CN CNB97199014XA patent/CN1182839C/zh not_active Expired - Lifetime
-
2000
- 2000-01-31 HK HK00100602A patent/HK1021620A1/xx not_active IP Right Cessation
-
2010
- 2010-04-22 JP JP2010099006A patent/JP5215347B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JP5215347B2 (ja) | 2013-06-19 |
JP2010215632A (ja) | 2010-09-30 |
ES2264173T3 (es) | 2006-12-16 |
HK1021620A1 (en) | 2000-06-23 |
CN100477986C (zh) | 2009-04-15 |
JP5173089B2 (ja) | 2013-03-27 |
CA2265668A1 (en) | 1998-06-04 |
EP0946151A1 (en) | 1999-10-06 |
AU5267698A (en) | 1998-06-22 |
CN1233953A (zh) | 1999-11-03 |
CA2265668C (en) | 2005-08-23 |
DE69735848D1 (de) | 2006-06-14 |
ATE325606T1 (de) | 2006-06-15 |
PT946151E (pt) | 2006-07-31 |
JP2002513392A (ja) | 2002-05-08 |
CN1182839C (zh) | 2005-01-05 |
CN1636552A (zh) | 2005-07-13 |
DE69735848T2 (de) | 2006-12-28 |
WO1998023263A1 (en) | 1998-06-04 |
EP0946151B1 (en) | 2006-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0946151T3 (da) | Doseringsform med stigende dosisfrigivelse | |
HK1127997A1 (en) | Dosage form and method for administering drug | |
PT957899E (pt) | Forma de dosagem para proporcionar um medicamento numa dose crescente | |
PT1035834E (pt) | Forma de dosagem osmotica que compreende primeiro e segundo revestimentos | |
ATE165000T1 (de) | Dosierungsform zur verzoegerten wirkstofffreisetzung | |
NO972780D0 (no) | Inhalasjonsanordning, fremgangsmåte for fordeling av et farmasöytisk aktivt stoff og fremgangsmåte for administrering av en dose med et farmasöytisk aktivt stoff | |
DK0663825T3 (da) | Anvendelse af melatonin i orale doser til fremkaldelse af søvn | |
NZ508526A (en) | Opioid formulations for treating pain | |
NO20006007D0 (no) | Fremgangsmåte til dosering av et medikament, samt doseringsform | |
GEP20022783B (en) | Method of Preventing and Delaying Onset of Alzheimer's Disease and Composition Therefor | |
NO305581B1 (no) | Anvendelse av et benaktivt fosfonat i kombinasjon med et °strogenhormon, og preparat i enhetsdoseform for behandling av osteoporose | |
DK0998287T3 (da) | Anvendelse af levobupivacain | |
ATE284206T1 (de) | Transdermal verabreichtes dextromethorphan als hustenmittel | |
SE9101341D0 (sv) | New medicinal use | |
SE9904424D0 (sv) | Use of interleukin-6 in combination with leptin in treatment of obesity | |
PL328924A1 (en) | Method of treating abuse of substances | |
ZA977873B (en) | Dosage form and method for administering drug. | |
AU8716001A (en) | Treatment of hepatitis c with thymosin and pegylated interferon | |
UA18878A (uk) | Спосіб лікуваhhя алкогольhої та hаркотичhої залежhості |